HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Beauty’s Sluggish 2012: The Cost Of Cutting Back?

This article was originally published in The Rose Sheet

Executive Summary

Kline’s Nancy Mills offers perspective on P&G performance in 2012 when the company saw its market share slip in certain personal-care categories. In her blog post, Mills attributes the erosion in part to the firm’s ongoing $10 billion cost-cutting initiative, which slowed new product introductions and left some brands under-supported in a highly competitive landscape, she says.

You may also be interested in...



OTC, Supplement Ad Spending Points To Bigger Jump For Full Year

Dietary supplement ad spending grew 23.5% in the 2013 first quarter after increasing 17% in 2012, Kantar Media data show. The OTC sector’s ad spend was not as large, but still strong, up 10% for first quarter 2013 after increasing 8% in full-year 2012.

OTC, Supplement Ad Spending Points To Bigger Jump For Full Year

Dietary supplement ad spending grew 23.5% in the 2013 first quarter after increasing 17% in 2012, Kantar Media data show. The OTC sector’s ad spend was not as large, but still strong, up 10% for first quarter 2013 after increasing 8% in full-year 2012.

Competition Drives Personal-Care Ad Spend In Early 2013 – Kantar Media

After creeping up 5% from 2011 to 2012, ad spending in 2013 is on pace to jump dramatically among the biggest players in the personal-care industry.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018452

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel